Turing Pharmaceuticals
- All
- News
-
'Most Hated Man' Gets Seven Years In Jail For Defrauding Investors
Infamous "Pharma Bro" Martin Shkreli, once dubbed the most hated man in America for ratcheting up the price of an HIV drug, was sentenced to seven years prison Friday on charges of defrauding investors.
-
Twitter Account of Pharmaceutical Executive Shkreli Hacked
"It was hacked," Craig Stevens, a spokesman for the former chief executive of Turing Pharmaceuticals, said in an email.
-
Turing Pharma Names Chairman To Replace Martin Shkreli As CEO
Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday.
-
Martin Shkreli, the Bad Boy of Pharmaceuticals, Hits Back
A former hedge fund manager, Shkreli drew the wrath of consumers, became a talking point in the presidential campaign and spurred federal and state inquiries as well as a dialogue about how and whether to control rising drug prices.
-
Life-Saving Pill That Had Its Price Hiked To $750 Now Has A $1 Competitor
Turing Pharmaceuticals chief executive Martin Shkreli found himself in the middle of a media firestorm last month as he adamantly defended his company's 4,000 percent drug price hike as "altruistic."
-
CEO Who Raised Price Of Old Pill More Than $700 Calls Journalist A 'Moron' For Asking Why
John Carroll, the editor of Fierce Biotech, a daily newsletter about the industry, was one of the first to ask Turing chief executive Martin Shkreli directly to explain the move.
-
'Most Hated Man' Gets Seven Years In Jail For Defrauding Investors
Infamous "Pharma Bro" Martin Shkreli, once dubbed the most hated man in America for ratcheting up the price of an HIV drug, was sentenced to seven years prison Friday on charges of defrauding investors.
-
Twitter Account of Pharmaceutical Executive Shkreli Hacked
"It was hacked," Craig Stevens, a spokesman for the former chief executive of Turing Pharmaceuticals, said in an email.
-
Turing Pharma Names Chairman To Replace Martin Shkreli As CEO
Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday.
-
Martin Shkreli, the Bad Boy of Pharmaceuticals, Hits Back
A former hedge fund manager, Shkreli drew the wrath of consumers, became a talking point in the presidential campaign and spurred federal and state inquiries as well as a dialogue about how and whether to control rising drug prices.
-
Life-Saving Pill That Had Its Price Hiked To $750 Now Has A $1 Competitor
Turing Pharmaceuticals chief executive Martin Shkreli found himself in the middle of a media firestorm last month as he adamantly defended his company's 4,000 percent drug price hike as "altruistic."
-
CEO Who Raised Price Of Old Pill More Than $700 Calls Journalist A 'Moron' For Asking Why
John Carroll, the editor of Fierce Biotech, a daily newsletter about the industry, was one of the first to ask Turing chief executive Martin Shkreli directly to explain the move.
